In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Mechanical Thrombectomy for Basilar Artery Acute Ischemic Strokes

    Final Number:
    1242

    Authors:
    Elias Atallah MD; Symeon Missios MD; Karim Hafazallah; Nohra Chalouhi MD; Stavropoula I. Tjoumakaris MD; Nabeel Herial MD; M. Reid Gooch MD; Robert H. Rosenwasser MD, FACS, FAHA; Hekmat Zarzour; Pascal Jabbour MD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2018 Annual Meeting

    Introduction: Neurointerventionists have been recently enthusiastic in performing endovascular mechanical thrombectomy(MT) for acute ischemic strokes of the posterior circulation(PC). Prompt repermeabilization of the PC has been linked to an increased survival rate. We aim to study the prominence, the safety and the clinical impact of PC-MT.

    Methods: Patient medical charts were retrospectively reviewed between2010-2017. Data on intra-venous tissue plasminogen activator(IV-rtPA), National Institute Health Stroke Scale(NIHSS), Alberta Stroke Program Early CT Scores(ASPECTS), per-procedural complications, mortality, and clinical outcomes, was gathered. The primary outcomes were:(1)safety of PC-MT ,(2)functional independence on latest follow-up(mRS score<2)(3)functional improvement on latest follow-up defined as a de-escalation by one of the mRSscore, and(4)overall mortality.

    Results: Of 234patients, 22(average age 60years, 41%female)had a MT performed for their PC stroke and constituted our population. All our patients, except one, had a basilar artery stroke. 2/22(9%)patients had a history of atrial fibrillation and4/22(18%)received IV-rtPA. The average NIHSS at admission was19(SD=8.2), the average DWI-ASPECTS score was5.4, the average CT-ASPECTS score was 7.3. 2/22(9%)patients had tandem embolus, and 3/22(13.6%)patients had reocclusion after endovascular therapy. The average time from onset of symptoms to procedure was 12hours(SD=8.8). 11/22(50%)patients had a delayed MT beyond 8hours from onset of symptoms. 10/22(45.5%)patients performed their MT with just Second Generation Stent-Retrievers(SGSR),2/22(9%)patients received therapy with large-bore aspiration catheters, 10/22(45.5%)patients received a salvage thrombus aspiration after failed first-line stent-retrievers thrombectomy. 10/22(45.5%)patients had a first-pass successful vessel recanalization mTICI>2. The average time of revascularization was61.6min(SD=31.50). 20/22(91%)had a mTICI>2b. The average patient follow-up was 95days(SD=105days). The average mRS on latest follow-up was 2.2. None of our patients died at latest follow-up. 63%had a decreased mRS score reflecting an amelioration of their functional status on latest follow-up.

    Conclusions: We recommend endovascular thrombectomy for patients with PC strokes. PC-MT should be performed safely beyond 8hours from onset of symptoms. MT would reduce long-term morbi-mortality in patients with PC strokes.

    Patient Care: To our knowledge, it is still unclear if MT should be used as a first-line treatment in PC-MT. Our study verifies this hypothesis and advocates for the use of MT(up to 24hours) in PC.

    Learning Objectives: MT is a safe and highly efficacious first-line therapy for acute BAOs. PC-MT provides a high rate of long-term functional independence, and guarantees a chance of functional improvement in a large portion of PCS patients. Delayed PC thrombectomy is broadly feasible and safe beyond 8hours, and should not be confined to patients presenting in the first 6hours from onset of symptoms.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy